Cartography, territory, property: postcolonial reflections on indigenous counter-mapping in Nicaragua and Belize

The attention given to indigenous peoples' use of maps to make claims to land and rights of self-government raises the question: what exactly it is that these maps do? This paper outlines an analytic for examining indigenous mapping projects, drawing upon two prominent instances - by the Maya of Belize and the Mayangna community of Awas Tingni in Nicaragua - where human rights lawsuits have been woven together with participatory mapping. In each case, map-making was intricately linked to the formulation of legal claims, resulting in a pair of much-celebrated maps and legal precedents regarding the recognition of indigenous land rights. We argue that these strategies do not reverse colonial social relations so much as they rework them. Notwithstanding the creativity expressed through these projects, they remain oriented by the spatial configuration of modern politics: territory and property rights. This spatial configuration both accounts for and limits the power of indigenous cartography. This impasse is not a contradiction that can be resolved; rather, it constitutes an aporia for which there is no easy or clear solution. Nonetheless, it must be confronted

OncoLog Volume 55, Volume 11-12, November-December 2010

Desmoid Tumors: Multidiciplinary treatment for an enigmatic disease Endoscopic Surgery for Skull Base Tumors: Patient selection is the key to success for the minimally invasive procedure INBRIEF: Earlier Breast Cancer Screening Recommended for Hispanic Women/SUMO Is Important for DNA Damage Repair/Regional Care Centers Make Cancer Treatment Easily Accessible/SIK2 Plays Critical Role in Chemotherapy Resistance HOUSE CALL: Books Provide Comfort, Guidence, Relaxationhttps://openworks.mdanderson.org/oncolog/1207/thumbnail.jp

Sesquiterpene Synthase Gene and Protein

The invention relates to sesquiterpene synthases and methods for their production and use. Particularly, the invention provides nucleic acids comprising the nucleotide sequence of citrus valencene synthase (CVS) which codes for at least one CVS. The invention further provides nucleic acids comprising the nucleotide sequence coding for amino acid residues forming the tier 1 and tier 2 domains of CVS. The invention also provides for methods of making and using the nucleic acids and amino acids of the current invention

OncoLog, Volume 62, Number 09, September 2017

Laser Interstitial Thermal Therapy for Spinal Metastases: Laser technique may be alternative to open surgery prior to stereotactic radiation therapy for metastases adjacent to the spinal cord. Immunotherapy Plus Targeted Therapy for Anaplastic Thyroid Cancer: Trial combines atezolizumab with targeted or cytotoxic agents for patients with anaplastic or poorly differentiated thyroid cancer. A New era in Follicular Lymphoma: Newly approved drugs, clinical trials represent shift from cytotoxic to targeted and immunotherapeutic agents. HOUSE CALL: Understanding Clinical Trials- Trials provide access to new cancer treatments INBRIEF: Repeat Surgery for Close Margins May Be Unnecessary for DCIS Patients Receiving Radiation Therapyhttps://openworks.mdanderson.org/oncolog/1280/thumbnail.jp

Oncolog, Volume 56, Number 09

Novel Agents for Castrate-Resistant Prostate Cancer Include Potent Androgen Blockers and Immunotherapies: Despite progress in screening and therapy, prostate cancer continues to be a leading cause of cancer death among men worldwide New Targeted Therapy Offers Hope in Relapsed Hodgkin and Anaplastic large-Cell Lymphoma: The U.S. Food and Drug Administration (FDA) has approved the first new drug for Hodgkin Lymphoma since 1977 HOUSE CALL: Colorectal Cancer Screening: Risk factors determine who should be screened and how often IN BRIEF: Everolimus may Overcome Trastuzumab Resistance in HER2-Positive Breast Cancer Patientshttps://openworks.mdanderson.org/oncolog/1215/thumbnail.jp

OncoLog Volume 55, Volume 03, March 2010

Benign Tumors That Cause Big Problems:Fortunately, parathyroid tumors can be removed with minimally invasive surgery. Preventing Bone Loss nad Fractures in Cancer Patients INBRIEF: Leukemia Cells Observed Burning Fat to Evade Death/Assesment Tool Takes Aim at Graft-versus-Host Disease House call: Immunotherapy:Boosting the Body\u27s Fight Against Cancerhttps://openworks.mdanderson.org/oncolog/1200/thumbnail.jp

Don\u27t Try To Steal The Sweetheart Of A Soldier

https://digitalcommons.library.umaine.edu/mmb-vp/3081/thumbnail.jp

OncoLog, Volume 62, Number 07, July 2017

RAS Mutations and Colorectal Cancer Liver Metastases: Gene mutations may have implications for local therapy for liver metastases from colorectal cancer. Active Surveillance for Prostate Cancer: Clinical trial may clarify which patients with prostate cancer will benefit from active surveillance rather than immediate treatment. Gut Microbiome May Affect Immunotherapy Response in Melanoma: Metastatic melanoma patients who experience responses to checkpoint inhibitors have a distinct gut bacterial genetic signature. HOUSE CALL: Cancer-Related fatigue-Tips for fighting fatiguehttps://openworks.mdanderson.org/oncolog/1278/thumbnail.jp

OncoLog, Volume 57, Number 04, April 2012

Biology, More Than Chemotherapy Timing, Drives Locoregional Recurrence in Patients Who Undergo Breast-Conserving Therapy: The management of breast cancer, like that of many cancers, often requires a little bit of everything: surgery, radiation therapy, and systemic therapy with chemotherapeutic drugs or other agents New Treatments for Acute Myelogenous Leukemia May Improve Patient Outcomes: Acute myelogenous leukemia (AML) is an aggressive and deadly malignancy, nut new treatments are being developed that may prolong remissions HOUSE CALL: Controlling Nausea and Vomiting from Chemotherapy: Several techniques can be used to prevent or reduce this side effecthttps://openworks.mdanderson.org/oncolog/1221/thumbnail.jp

OncoLog, Volume 62, Number 11-12, November - December 2017

Managing Chemotherapy-Induced Neuropathy: Neuromodulation, pharmacological treatments show promise against peripheral neuropathy in cancer patients. Treating Tobacco Addiction: MD Anderson provides pharmacotherapy, counseling to help smokers quit plus cessation education, resources for community practitioners HOUSE CALL: Smoking-Related Cancers- Cancer risks from tobacco are not limited to the lungs, but quitting reduces these riskshttps://openworks.mdanderson.org/oncolog/1282/thumbnail.jp